Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Porcu, Pierluigi
One or more keywords matched the following items that are connected to Porcu, Pierluigi
Item TypeName
Concept B-Lymphocytes
Concept Cells, Cultured
Concept Clone Cells
Concept Dendritic Cells
Concept Killer Cells, Natural
Concept Lymphocytes
Concept Receptors, Antigen, T-Cell
Concept T-Lymphocytes
Concept Tumor Cells, Cultured
Concept Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
Concept Leukemia, T-Cell
Concept Leukemia-Lymphoma, Adult T-Cell
Concept Leukemia, Prolymphocytic, T-Cell
Concept CD4-Positive T-Lymphocytes
Concept T-Lymphocyte Subsets
Concept Lymphoma, T-Cell
Concept Lymphoma, T-Cell, Cutaneous
Concept Lymphoma, T-Cell, Peripheral
Concept Receptors, Antigen, T-Cell, alpha-beta
Concept CD8-Positive T-Lymphocytes
Concept Jurkat Cells
Concept Genes, T-Cell Receptor beta
Concept K562 Cells
Concept Natural Killer T-Cells
Academic Article A look at the National Comprehensive Cancer Network guidelines for cutaneous lymphomas.
Academic Article The state of cutaneous lymphomas: a call to action.
Academic Article Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Academic Article CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
Academic Article Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
Academic Article The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.
Academic Article Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
Academic Article Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Academic Article We should have a dream: unlocking the workings of the genome in cutaneous T-cell lymphomas.
Academic Article Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
Academic Article Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.
Academic Article Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
Academic Article Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).
Academic Article New targets of therapy in T-cell lymphomas.
Academic Article Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.
Academic Article Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Academic Article Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
Academic Article Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder.
Academic Article Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Academic Article MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.
Academic Article Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Academic Article A positive randomised trial in cutaneous T-cell lymphoma.
Academic Article Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Academic Article The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
Academic Article Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
Academic Article Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Academic Article Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
Academic Article Treating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensator.
Academic Article Activity of the PI3K-d,? inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Academic Article Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Academic Article Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
Academic Article Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
Academic Article Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.
Academic Article Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Academic Article Early CTCL diagnosis, a (miR)age no more?
Academic Article Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.
Academic Article Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.
Academic Article Sézary Syndrome: Clinical and Biological Aspects.
Academic Article Expanding and expounding the genomic map of CTCL.
Academic Article Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Academic Article Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
Academic Article Preclinical Targeting of MicroRNA-214 in Cutaneous T-cell Lymphoma (CTCL).
Academic Article Emerging insights on the biology and treatment of cutaneous T-cell lymphoma.
Academic Article Cutaneous CD4+ CD56+ hematologic malignancies.
Academic Article Systemic therapy of cutaneous T-cell lymphoma (CTCL).
Academic Article Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?
Academic Article IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Academic Article Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
Academic Article Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL).
Academic Article Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
Academic Article T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Academic Article Improved outcomes for extranodal natural killer T-cell lymphoma.
Academic Article Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Academic Article Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes.
Academic Article Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.
Academic Article Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Academic Article Take (STAT)5: jazzing up T-cell leukemia.
Academic Article Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression.
Academic Article Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.
Academic Article Atypical lymphocytic lobular panniculitis: a clonal subcutaneous T-cell dyscrasia.
Academic Article Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Academic Article Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor.
Academic Article Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.
Academic Article Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms.
Academic Article Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides.
Academic Article The overlap of skin and blood T-cell clones in early-stage mycosis fungoides.
Academic Article Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.
Academic Article Front-line Chemo-immunotherapy with Nivolumab and Dose-Adjusted EPOCH in Peripheral T-cell Lymphoma: A Phase I Trial.
Academic Article Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events.
Academic Article XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
Academic Article The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.
Academic Article Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia.
Academic Article Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.
Academic Article The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-cell Lymphoma.
Search Criteria
  • T Lymphocytes